These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7994064

  • 1. Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro.
    Eaves C, Eaves A.
    Blood Cells; 1994; 20(1):83-93; discussion 93-5. PubMed ID: 7994064
    [Abstract] [Full Text] [Related]

  • 2. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.
    Cashman JD, Eaves AC, Eaves CJ.
    Leukemia; 1992 Sep; 6(9):886-92. PubMed ID: 1518302
    [Abstract] [Full Text] [Related]

  • 3. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells.
    Otsuka T, Eaves CJ, Humphries RK, Hogge DE, Eaves AC.
    Leukemia; 1991 Oct; 5(10):861-8. PubMed ID: 1961020
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
    Holyoake TL, Freshney MG, Sproul AM, Richmond LJ, Alcorn MJ, Steward WP, Fitzsimons E, Dunlop DJ, Franklin IM, Pragnell IB.
    Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
    [Abstract] [Full Text] [Related]

  • 6. Continuous activation of primitive hematopoietic cells in long-term human marrow cultures containing irradiated tumor cells.
    Otsuka T, Humphries RK, Hogge DE, Eaves AC, Eaves CJ.
    J Cell Physiol; 1991 Sep; 148(3):370-9. PubMed ID: 1717496
    [Abstract] [Full Text] [Related]

  • 7. MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures.
    Cashman JD, Eaves CJ, Sarris AH, Eaves AC.
    Blood; 1998 Oct 01; 92(7):2338-44. PubMed ID: 9746772
    [Abstract] [Full Text] [Related]

  • 8. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R, McGlave PB, Miller JS, Wissink S, Lin WN, Verfaillie CM.
    Exp Hematol; 1997 Aug 01; 25(9):980-91. PubMed ID: 9257812
    [Abstract] [Full Text] [Related]

  • 9. Maintenance and proliferation control of primitive hemopoietic progenitors in long-term cultures of human marrow cells.
    Eaves AC, Eaves CJ.
    Blood Cells; 1988 Aug 01; 14(2-3):355-68. PubMed ID: 3228586
    [Abstract] [Full Text] [Related]

  • 10. Biological strategies for the selective manipulation of normal and leukemic stem cells.
    Eaves CJ, Cashman JD, Zoumbos NC, Barnett MJ, Eaves AC.
    Stem Cells; 1993 Oct 01; 11 Suppl 3():109-21. PubMed ID: 7905319
    [Abstract] [Full Text] [Related]

  • 11. Differences between normal and CML stem cells: potential targets for clinical exploitation.
    Eaves AC, Barnett MJ, Ponchio L, Cashman JD, Petzer AL, Eaves CJ.
    Stem Cells; 1998 Oct 01; 16 Suppl 1():77-83; discussion 89. PubMed ID: 11012149
    [Abstract] [Full Text] [Related]

  • 12. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A, Rosas-Cabral A, Vela-Ojeda J, González JC, Mayani H.
    Leuk Res; 2004 Jun 01; 28(6):639-47. PubMed ID: 15120942
    [Abstract] [Full Text] [Related]

  • 13. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.
    Eaves CJ, Cashman JD, Wolpe SD, Eaves AC.
    Proc Natl Acad Sci U S A; 1993 Dec 15; 90(24):12015-9. PubMed ID: 8265663
    [Abstract] [Full Text] [Related]

  • 14. In vitro culture of bone marrow cells for autografting in CML.
    Eaves CJ, Barnett MJ, Eaves AC.
    Leukemia; 1993 Aug 15; 7 Suppl 2():S126-9. PubMed ID: 8361215
    [Abstract] [Full Text] [Related]

  • 15. The biology of normal and neoplastic stem cells in CML.
    Eaves C, Udomsakdi C, Cashman J, Barnett M, Eaves A.
    Leuk Lymphoma; 1993 Aug 15; 11 Suppl 1():245-53. PubMed ID: 8251904
    [Abstract] [Full Text] [Related]

  • 16. Growth control in leukemia.
    Eaves AC, Eaves CJ.
    Prog Clin Biol Res; 1990 Aug 15; 354A():223-36. PubMed ID: 2247489
    [Abstract] [Full Text] [Related]

  • 17. Interferon-alpha alters the distribution of CFU-GM between the adherent and nonadherent compartments in long-term cultures of chronic myeloid leukemia marrow.
    Osterholz J, Dowding C, Guo AP, Siczkowski M, Goldman JM.
    Exp Hematol; 1991 Jun 15; 19(5):326-31. PubMed ID: 2026184
    [Abstract] [Full Text] [Related]

  • 18. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
    Schultheis B, Heissig B, Pasternak G, Hörner S, Hehlmann R.
    Folia Biol (Praha); 2000 Jun 15; 46(6):251-5. PubMed ID: 11140858
    [Abstract] [Full Text] [Related]

  • 19. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
    Schultheis B, Pasternak G, Hehlmann R.
    Folia Biol (Praha); 2000 Jun 15; 46(6):256-63. PubMed ID: 11140859
    [Abstract] [Full Text] [Related]

  • 20. Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia.
    Fujisaki T, Otsuka T, Gondo H, Okamura T, Niho Y, Ohhinata A, Abe F.
    Int Immunopharmacol; 2003 Jun 15; 3(6):901-7. PubMed ID: 12781706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.